https://old.isofolmedical.com/mfn_news/ 2025-09-30T13:00:00+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-bjuder-in-till-investerarmote-den-19-mars/ 2024-03-12T10:30:03+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-slutsatser-fran-den-fordjupade-analysen-av-agent-studien/ 2024-03-21T13:53:23+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-en-klinisk-utvecklingsplan-for-arfolitixorin/ 2024-03-22T15:49:48+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-march-2024/ 2024-05-08T06:07:20+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2024/ 2024-05-08T06:07:39+00:00 https://old.isofolmedical.com/mfn_news/isofol-and-charite-sign-collaboration-agreement-on-further-clinical-development-of-arfolitixorin/ 2024-05-24T13:59:19+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-magdalena-hagman-as-new-chief-financial-officer/ 2024-07-30T10:29:31+00:00 https://old.isofolmedical.com/mfn_news/a-late-breaking-abstract-concerning-arfolitixorin-will-be-presented-at-ena-2024-today/ 2024-10-24T06:32:27+00:00 https://old.isofolmedical.com/sv/mfn_news/ett-late-breaking-abstract-rorande-arfolitixorin-presenteras-pa-ena-2024-idag/ 2024-10-24T06:50:50+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-has-been-accepted-for-presentation-at-asco-gi-2025/ 2025-01-25T11:53:16+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-year-end-report-january-december-2024/ 2025-03-20T14:19:53+00:00 https://old.isofolmedical.com/mfn_news/isofol-establish-advisory-board-with-leading-experts/ 2025-03-27T09:41:04+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-11-june-2025/ 2025-06-18T14:13:15+00:00 https://old.isofolmedical.com/mfn_news/isofol-completes-first-cohort-in-ongoing-clinical-study-with-arfolitixorin/ 2025-06-18T14:13:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-slutfor-forsta-kohorten-i-pagaende-klinisk-studie-med-arfolitixorin/ 2025-06-18T14:13:15+00:00 https://old.isofolmedical.com/mfn_news/isofol-publishes-prospectus-in-connection-with-the-companys-rights-issue/ 2025-06-18T14:13:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-offentliggor-prospekt-i-samband-med-bolagets-foretradesemission/ 2025-06-18T14:13:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-uppstart-av-nytt-advisory-board-i-samband-med-asco-2025/ 2025-06-18T14:13:16+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-the-launch-of-new-advisory-board-in-connection-with-asco-2025/ 2025-06-18T14:13:16+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-final-terms-of-the-rights-issue-and-the-potential-overallotment-issue/ 2025-06-18T14:13:16+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-offentliggor-slutliga-villkor-i-foretradesemission-samt-for-en-potentiell-overtilldelningsemission/ 2025-06-18T14:13:16+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-11-juni-2025/ 2025-06-18T14:13:16+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-beviljas-pre-ind-mote-med-fda-for-arfolitixorin/ 2025-06-18T14:13:17+00:00 https://old.isofolmedical.com/mfn_news/isofol-granted-pre-ind-meeting-with-the-fda-for-arfolitixorin/ 2025-06-18T14:13:17+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-21-2025/ 2025-06-18T14:13:17+00:00 https://old.isofolmedical.com/sv/mfn_news/intervju-med-isofols-vd-petter-segelman-lindqvist-om-forestaende-foretradesemission/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/mfn_news/interview-with-isofols-ceo-petter-segelman-lindqvist-on-upcoming-rights-issue/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-march-2025/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2025/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-21-maj-2025/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-den-11-juni-2025-i-isofol-medical-ab-publ/ 2025-06-18T14:13:18+00:00 https://old.isofolmedical.com/mfn_news/notice-to-attend-the-extraordinary-general-meeting-held-on-june-11-2025-in-isofol-medical-ab-publ/ 2025-06-18T14:13:19+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-inkluderar-forsta-patienten-i-en-klinisk-fas-ib-ii-studie-med-arfolitixorin/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/mfn_news/isofol-includes-first-patient-in-a-clinical-phase-ib-ii-study-of-arfolitixorin/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/sv/mfn_news/styrelsen-i-isofol-beslutar-om-en-fullt-garanterad-foretradesemission-av-units-om-cirka-85-miljoner-kronor-samt-foreslar-en-overtilldelningsemission-om-cirka-10-miljoner-kronor/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/mfn_news/the-board-of-directors-of-isofol-resolves-on-a-fully-guaranteed-rights-issue-of-units-amounting-to-approximately-sek-85-million-and-proposes-an-over-allotment-issue-of-approximately-sek-10-million/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/mfn_news/notice-to-attend-the-annual-general-meeting-held-on-may-21-2025-in-isofol-medical-ab-publ/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-den-21-maj-2025-i-isofol-medical-ab-publ/ 2025-06-18T14:13:20+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-partner-solasia-avser-utoka-investeringen-i-kommande-studier-av-arfolitixorin/ 2025-06-18T14:13:21+00:00 https://old.isofolmedical.com/mfn_news/isofols-partner-solasia-intends-to-increase-investments-in-upcoming-trials-with-arfolitixorin/ 2025-06-18T14:13:21+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2024/ 2025-06-18T14:13:21+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2024/ 2025-06-18T14:13:21+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-etablerar-advisory-board-med-ledande-experter/ 2025-06-18T14:13:22+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-regulatory-approval-to-initiate-clinical-study-of-arfolitixorin/ 2025-06-18T14:13:22+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-erhaller-myndighetsgodkannande-for-att-inleda-klinisk-studie-med-arfolitixorin/ 2025-06-18T14:13:22+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utokar-natverk-av-radgivare-med-framstaende-expert/ 2025-06-18T14:13:22+00:00 https://old.isofolmedical.com/mfn_news/isofol-expands-network-of-advisors-with-prominent-expert/ 2025-06-18T14:13:23+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-pa-stora-aktiedagarna-den-12-mars/ 2025-06-18T14:13:23+00:00 https://old.isofolmedical.com/mfn_news/isofol-presents-at-stora-aktiedagarna-on-march-12/ 2025-06-18T14:13:23+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-vid-flera-kommande-investerarmoten/ 2025-06-18T14:13:23+00:00 https://old.isofolmedical.com/mfn_news/isofol-presents-at-several-upcoming-investor-meetings/ 2025-06-18T14:13:23+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2024/ 2025-06-18T14:13:24+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-roger-tell-as-chief-medical-officer-ahead-of-initiation-of-clinical-study/ 2025-06-18T14:13:24+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-anstaller-roger-tell-som-medicinsk-chef-infor-start-av-klinisk-studie/ 2025-06-18T14:13:24+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-the-presentation-of-a-post-hoc-analysis-of-the-phase-iii-study-agent-at-the-2025-asco-gi-symposium/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-en-post-hoc-analys-av-fas-iii-studien-agent-publicerats-som-abstract-vid-asco-gi-2025/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/mfn_news/isofol-and-its-partner-solasia-plan-to-expand-the-upcoming-clinical-trial-of-arfolitixorin-to-japan/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-och-samarbetspartnern-solasia-planerar-att-expandera-den-kommande-kliniska-studien-av-arfolitixorin-till-japan/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-investigator-initiated-study-of-arfolitixorin-has-been-published-in-bjc-reports/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-att-en-provarinitierad-studie-av-arfolitixorin-har-publicerats-i-bjc-reports/ 2025-06-18T14:13:25+00:00 https://old.isofolmedical.com/mfn_news/isofol-provides-an-operational-update-during-investor-meeting/ 2025-06-18T14:13:26+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-lamnar-en-operationell-uppdatering-under-investerarmote/ 2025-06-18T14:13:26+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2025/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-utsett-valberedningen-infor-arsstamman-2025/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2024/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-september-2024/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-att-ett-abstract-accepterats-for-presentation-pa-asco-gi-2025/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/mfn_news/isofol-invites-to-investor-meeting-on-november-20-2024/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-bjuder-in-till-investerarmote-den-20-november-2024/ 2025-06-18T14:13:27+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-a-late-breaking-abstract-has-been-accepted-by-ena-2024/ 2025-06-18T14:13:28+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-att-ett-late-breaking-abstract-accepterats-for-presentation-pa-ena-2024/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/mfn_news/isofol-strengthens-the-outlook-for-further-extending-the-patent-protection-of-its-drug-candidate-arfolitixorin/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-starker-utsikterna-for-utokat-patentskydd-av-lakemedelskandidaten-arfolitixorin/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-avslutar-avtal-om-likviditetsgaranti/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/mfn_news/isofol-terminates-liquidity-guarantee-agreement/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-june-2024/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2024/ 2025-06-18T14:13:29+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-margareta-hagman-till-ny-chief-financial-officer/ 2025-06-18T14:13:30+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-new-preclinical-data-supporting-the-previously-communicated-clinical-development-plan-for-arfolitixorin/ 2025-06-18T14:13:30+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-nya-prekliniska-data-stoder-den-tidigare-annonserade-kliniska-utvecklingsplanen-for-arfolitixorin/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-a-post-hoc-per-protocol-analysis-of-the-agent-study-further-supporting-arfolitixorins-continued-clinical-development/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-en-post-hoc-analys-per-protokoll-av-agent-studien-ger-ytterligare-stod-for-arfolitixorins-fortsatta-kliniska-utveckling/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/mfn_news/isofols-chief-financial-officer-to-leave-the-company/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-chief-financial-officer-lamnar-bolaget/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-och-charite-har-tecknat-ett-samarbetsavtal-om-vidare-klinisk-utveckling-av-arfolitixorin/ 2025-06-18T14:13:31+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-8-2024/ 2025-06-18T14:13:32+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-8-maj-2024/ 2025-06-18T14:13:32+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2023/ 2025-06-18T14:13:32+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2023/ 2025-06-18T14:13:33+00:00 https://old.isofolmedical.com/mfn_news/notice-to-attend-the-annual-general-meeting-held-on-may-8-2024-in-isofol-medical-ab-publ/ 2025-06-18T14:13:33+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-den-8-maj-2024-i-isofol-medical-ab-publ/ 2025-06-18T14:13:33+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-japanska-partner-solasia-har-beslutat-att-intensifiera-sitt-engagemang-i-den-kliniska-utvecklingen-av-arfolitixorin/ 2025-06-18T14:13:33+00:00 https://old.isofolmedical.com/mfn_news/isofols-japanese-partner-solasia-intensifies-its-commitment-to-the-clinical-development-of-arfolitixorin/ 2025-06-18T14:13:33+00:00 https://old.isofolmedical.com/mfn_news/isofol-presents-a-clinical-development-plan-for-arfolitixorin/ 2025-06-18T14:13:34+00:00 https://old.isofolmedical.com/mfn_news/isofol-invites-to-investor-meeting-on-march-19/ 2025-06-18T14:13:34+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-year-end-report-january-december-2023/ 2025-06-18T14:13:34+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2023/ 2025-06-18T14:13:35+00:00 https://old.isofolmedical.com/sv/mfn_news/styrelsen-i-isofol-inleder-planeringen-av-kliniska-studier-och-kommer-att-annonsera-en-strategisk-utvecklingsplan-den-19-mars/ 2025-06-18T14:13:35+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-of-directors-decides-to-initiate-the-planning-of-clinical-studies-and-will-announce-a-strategic-development-plan-on-march-19/ 2025-06-18T14:13:35+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-magnus-hurst-as-new-chief-financial-officer/ 2025-06-18T14:13:35+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-magnus-hurst-till-ny-chief-financial-officer/ 2025-06-18T14:13:35+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-petter-segelman-lindqvist-as-new-ceo/ 2025-06-18T14:13:36+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-petter-segelman-lindqvist-till-ny-verkstallande-direktor/ 2025-06-18T14:13:36+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-4-januari-2024/ 2025-06-18T14:13:36+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-january-4-2024/ 2025-06-18T14:13:36+00:00 https://old.isofolmedical.com/mfn_news/isofol-presents-additional-results-from-laboratory-tests-with-arfolitixorin-showing-supplementary-effects/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-ytterligare-resultat-fran-laboratorietester-med-arfolitixorin-som-visar-tillaggseffekter/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/sv/mfn_news/styrelsen-i-isofol-meddelar-sin-installning-till-minoritetsaktieagares-forslag-infor-extra-bolagsstamma/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-of-directors-announces-its-position-on-minority-shareholders-proposal-ahead-of-extraordinary-general-meeting/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-tagit-del-av-de-forsta-resultaten-fran-laboratorieforsok-med-arfolitixorin/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-received-the-first-results-from-laboratory-tests-of-arfolitixorin/ 2025-06-18T14:13:37+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-avvecklar-dotterbolag/ 2025-06-18T14:13:38+00:00 https://old.isofolmedical.com/mfn_news/isofol-is-liquidating-a-subsidiary/ 2025-06-18T14:13:38+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-4-januari-2024/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/mfn_news/notice-convening-the-extraordinary-general-meeting-in-isofol-medical-ab-publ-4-january-2024/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2023/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-september-2023/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-obtained-a-request-to-call-an-extraordinary-general-meeting/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-erhallit-begaran-om-att-kalla-till-extra-bolagsstamma/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2024/ 2025-06-18T14:13:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-utsett-valberedningen-infor-arsstamman-2024/ 2025-06-18T14:13:40+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-has-taken-note-of-the-results-from-the-modelle-001-study/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-har-tagit-del-av-resultatet-fran-modelle-001-studien/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-june-2023/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2023/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/mfn_news/isofol-presents-conclusions-from-the-in-depth-analysis-of-the-agent-study/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-styrelse-utser-roger-tell-som-tillforordnad-vd-for-bolaget/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-of-directors-appoints-roger-tell-as-acting-ceo-of-the-company/ 2025-06-18T14:13:41+00:00 https://old.isofolmedical.com/mfn_news/ceo-resigns-at-his-own-request-in-isofol-medical-ab-publ/ 2025-06-18T14:13:42+00:00 https://old.isofolmedical.com/sv/mfn_news/vd-avgar-pa-egen-begaran-i-isofol-medical-ab-publ/ 2025-06-18T14:13:42+00:00 https://old.isofolmedical.com/mfn_news/changes-in-the-board-at-isofol-medical-ab-publ/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/sv/mfn_news/forandring-i-styrelsen-hos-isofol-medical-ab-publ/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-3-maj-2023/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-3-2023/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-march-2023/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2023/ 2025-06-18T14:13:43+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-inleder-preklinisk-utvardering-av-arfolitixorin-med-oncosyne-as/ 2025-06-18T14:13:44+00:00 https://old.isofolmedical.com/mfn_news/isofol-initiates-preclinical-evaluation-of-arfolitixorin-with-oncosyne-as/ 2025-06-18T14:13:44+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-report-for-the-first-quarter-of-2023/ 2025-06-18T14:13:44+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-delarsrapport-for-forsta-kvartalet-2023/ 2025-06-18T14:13:44+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2022/ 2025-06-18T14:13:45+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2022/ 2025-06-18T14:13:45+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-den-3-maj-2023-i-isofol-medical-ab-publ/ 2025-06-18T14:13:45+00:00 https://old.isofolmedical.com/mfn_news/isofols-appoints-roy-jonebrant-as-new-acting-chief-financial-officer/ 2025-06-18T14:13:45+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-roy-jonebrant-till-ny-tillforordnad-chief-financial-officer/ 2025-06-18T14:13:46+00:00 https://old.isofolmedical.com/mfn_news/isofol-initiates-a-stepwise-process-for-the-continued-development-of-its-drug-candidate-arfolitixorin/ 2025-06-18T14:13:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-initierar-en-stegvis-process-for-den-fortsatta-utvecklingen-av-lakemedelskandidaten-arfolitixorin/ 2025-06-18T14:13:46+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-appoints-thomas-andersson-as-new-ceo-of-the-company/ 2025-06-18T14:13:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-styrelse-utser-thomas-andersson-till-ny-vd-for-foretaget/ 2025-06-18T14:13:46+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-28-februari-2023/ 2025-06-18T14:13:47+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-february-28-2023/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-year-end-report-january-december-2022/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2022/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-february-13-2023/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-13-februari-2023/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-delarsrapport-for-fjarde-kvartalet-2022/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-report-for-the-fourth-quarter-of-2022/ 2025-06-18T14:13:48+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-28-februari-2023/ 2025-06-18T14:13:49+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-obtained-a-request-to-call-for-an-extraordinary-general-meeting/ 2025-06-18T14:13:49+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-erhallit-en-begaran-om-att-kalla-till-extra-bolagsstamma/ 2025-06-18T14:13:49+00:00 https://old.isofolmedical.com/mfn_news/isofol-invites-to-an-informational-meeting-on-january-30-prior-to-extraordinary-general-meeting/ 2025-06-18T14:13:50+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-bjuder-in-till-informationsmote-den-30-januari-infor-extra-bolagsstamma/ 2025-06-18T14:13:50+00:00 https://old.isofolmedical.com/mfn_news/notice-convening-the-extraordinary-general-meeting-in-isofol-medical-ab-publ-13-february-2023/ 2025-06-18T14:13:50+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-den-13-februari-2023/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/mfn_news/isofol-medicals-board-of-directors-intends-to-call-an-extraordinary-general-meeting-with-proposals-for-dividends-and-liquidation-of-the-company/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-styrelse-avser-kalla-till-extra-bolagsstamma-med-forslag-till-utdelning-och-likvidation-av-bolaget/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-cfo-and-deputy-ceo-gustaf-albert-to-step-down-during-2023/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medicals-cfo-och-vice-vd-gustaf-albert-lamnar-under-2023/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medicals-vd-ulf-jungnelius-slutar-den-1-juni-2023/ 2025-06-18T14:13:51+00:00 https://old.isofolmedical.com/mfn_news/ceo-ulf-jungnelius-to-leave-isofol-medical-on-june-1-2023/ 2025-06-18T14:13:52+00:00 https://old.isofolmedical.com/sv/mfn_news/agent-studiens-slutliga-data-bekraftar-topline-resultaten/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/mfn_news/final-data-from-the-agent-study-confirms-topline-results/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2022/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-september-2022/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-utsett-valberedningen-infor-arsstamman-2023/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2023/ 2025-06-18T14:13:53+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-report-for-the-third-quarter-of-2022/ 2025-06-18T14:13:54+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-delarsrapport-for-tredje-kvartalet-2022/ 2025-06-18T14:13:54+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-data-from-the-agent-study/ 2025-06-18T14:13:54+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-redovisar-data-fran-agent-studien/ 2025-06-18T14:13:54+00:00 https://old.isofolmedical.com/mfn_news/isofol-provides-update-on-the-agent-study/ 2025-06-18T14:13:55+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-statusuppdatering-kring-agent-studien/ 2025-06-18T14:13:55+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-june-2022/ 2025-06-18T14:13:55+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2022/ 2025-06-18T14:13:55+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-delarsrapport-for-andra-kvartalet-2022/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-report-for-the-second-quarter-of-2022/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-toplineresultat-fran-fas-iii-studien-agent-varken-det-primara-eller-det-viktigaste-sekundara-effektmatten-uppnaddes/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-topline-results-of-phase-iii-agent-study-did-not-meet-primary-or-key-secondary-endpoints/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-erhaller-patentgodkannande-for-biomarkoranalys-och-avsikt-att-bevilja-godkannande-av-patentansokan-for-studiedosregim-i-europa/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-approval-of-biomarker-analysis-patent-and-intention-to-grant-patent-application-for-study-dose-regimen-in-europe/ 2025-06-18T14:13:56+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-justerar-starttiden-for-det-livesanda-fou-eventet-den-20-juni-till-kl-14-00/ 2025-06-18T14:13:57+00:00 https://old.isofolmedical.com/mfn_news/isofol-updates-start-time-of-live-streamed-rd-event-on-june-20-to-1400-cest/ 2025-06-18T14:13:57+00:00 https://old.isofolmedical.com/mfn_news/isofol-invites-to-a-live-streamed-rd-event-on-june-20-at-12-30-cest/ 2025-06-18T14:13:57+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-arrangerar-livesant-fou-evenemang-den-20-juni-kl-1230/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-19-2022/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-19-maj-2022/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/sv/mfn_news/vd-anforande-infor-arsstamma-2022-har-publicerats/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-march-2022/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2022/ 2025-06-18T14:13:58+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-delarsrapport-for-forsta-kvartalet-2022/ 2025-06-18T14:13:59+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-report-for-the-first-quarter-of-2022/ 2025-06-18T14:13:59+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2021/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2021/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-start-of-study-data-analysis-of-phase-iii-agent-study-in-advanced-metastatic-colorectal-cancer/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-paborjar-analysen-av-studiedata-fran-fas-iii-studien-agent-inom-metastaserad-kolorektalcancer/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/mfn_news/notice-to-attend-the-annual-general-meeting-held-on-may-19-2022-in-isofol-medical-ab-publ/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-den-19-maj-2022-i-isofol-medical-ab-publ/ 2025-06-18T14:14:00+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-abs-publ-nomination-committee-proposes-new-chair-of-the-board/ 2025-06-18T14:14:01+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-valberedning-foreslar-ny-ordforande/ 2025-06-18T14:14:01+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2021/ 2025-06-18T14:14:01+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-year-end-report-january-december-2021/ 2025-06-18T14:14:02+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-presentation-av-isofols-bokslutskommunike-2021-den-24-februari-2022/ 2025-06-18T14:14:02+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-presentation-of-isofols-year-end-report-2021-on-february-24-2022/ 2025-06-18T14:14:02+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-uppmarksammar-varldscancerdagen-den-4-februari/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/mfn_news/isofol-recognizes-world-cancer-day-on-february-4/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-appoints-jenny-sundqvist-as-chief-commercial-officer/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-utser-jenny-sundqvist-till-chief-commercial-officer-cco/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-invites-to-an-audiocast-on-december-6-at-08-00-a-m-cet/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-bjuder-in-till-audiocast-den-6-december-klockan-0800-cet/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-will-not-reach-300-pfs-events-in-the-agent-study-with-current-censoring-rules-based-on-fda-decision/ 2025-06-18T14:14:03+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-nar-inte-300-pfs-handelser-i-agent-studien-med-nuvarande-censureringsregler-baserat-pa-fda-beslut/ 2025-06-18T14:14:04+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-receives-fda-fast-track-designation-for-arfolitixorin-in-advanced-colorectal-cancer-mcrc/ 2025-06-18T14:14:05+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-beviljas-fast-track-designation-av-fda-for-arfolitixorin-for-behandling-av-avancerad-kolorektal-cancer/ 2025-06-18T14:14:05+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-utsett-valberedningen-infor-arsstamman-2022/ 2025-06-18T14:14:05+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2022/ 2025-06-18T14:14:05+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2021/ 2025-06-18T14:14:05+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-for-january-september-2021/ 2025-06-18T14:14:06+00:00 https://old.isofolmedical.com/mfn_news/trading-in-isofols-shares-commences-today-on-nasdaq-stockholm/ 2025-06-18T14:14:06+00:00 https://old.isofolmedical.com/sv/mfn_news/handeln-i-isofols-aktier-inleds-idag-pa-nasdaq-stockholm/ 2025-06-18T14:14:06+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-prospectus-and-new-financial-information-in-connection-with-listing-on-nasdaq-stockholm/ 2025-06-18T14:14:06+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-prospekt-och-ny-finansiell-information-i-samband-med-notering-pa-nasdaq-stockholm/ 2025-06-18T14:14:07+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-intends-to-list-its-shares-on-nasdaq-stockholm/ 2025-06-18T14:14:07+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-avser-att-notera-sina-aktier-pa-nasdaq-stockholm/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/mfn_news/company-presentation-at-lsx-nordic-congress-2021/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/sv/mfn_news/foretagspresentation-i-samband-med-lsx-nordic-congress-2021/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2021/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/mfn_news/bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-june-23-2021/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-23-juni-2021/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/sv/mfn_news/vd-anforande-infor-arsstamma-2021-har-publicerats/ 2025-06-18T14:14:08+00:00 https://old.isofolmedical.com/sv/mfn_news/andring-av-styrelsens-forslag-till-arsstamman-2021-avseende-bemyndigande/ 2025-06-18T14:14:09+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillfors-500-miljoner-kronor-genom-overtecknad-foretradesemission-och-utnyttjad-overtilldelningsoption/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/mfn_news/isofol-raises-sek-500-million-in-oversubscribed-rights-issue-and-exercised-over-allotment-option/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/mfn_news/isofol-publishes-prospectus-in-connection-with-the-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-offentliggor-prospekt-i-samband-med-den-fullt-garanterade-foretradesemissionen-om-cirka-400-miljoner-kronor/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-den-23-juni-2021-i-isofol-medical-ab-publ/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-of-directors-resolves-on-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/sv/mfn_news/styrelsen-i-isofol-har-beslutat-om-en-fullt-garanterad-foretradesemission-om-cirka-400-miljoner-kronor/ 2025-06-18T14:14:10+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-14-maj-2021/ 2025-06-18T14:14:11+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2021/ 2025-06-18T14:14:11+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2020/ 2025-06-18T14:14:11+00:00 https://old.isofolmedical.com/mfn_news/isofol-completes-recruitment-of-japanese-patients-in-the-global-phase-iii-agent-study/ 2025-06-18T14:14:12+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-slutfor-rekryteringen-av-japanska-patienter-i-den-globala-fas-iii-agent-studien/ 2025-06-18T14:14:12+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-senarelagger-arsstamman-2021/ 2025-06-18T14:14:12+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-den-14-maj-2021-i-isofol-medical-ab-publ/ 2025-06-18T14:14:12+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-sin-avsikt-att-genomfora-en-fullt-garanterad-foretradesemission-om-cirka-400-miljoner-kronor-och-en-potentiell-overtilldelningsoption-om-upp-till-cirka-100-miljoner-kronor/ 2025-06-18T14:14:12+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-its-intention-to-carry-out-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million-and-a-potential-over-allotment-option-of-up-to-approximately-sek-100-million/ 2025-06-18T14:14:13+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsbolagsstamma-den-20-maj-2021-i-isofol-medical-ab-publ/ 2025-06-18T14:14:13+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-far-besked-om-att-clinical-use-patent-for-lakemedelskandidaten-arfolitixorin-i-europa-kommer-att-godkannas/ 2025-06-18T14:14:13+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-notice-that-clinical-use-patent-in-europe-for-drug-candidate-arfolitixorin-will-be-approved/ 2025-06-18T14:14:13+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-a-conference-call-and-webcast-in-connection-with-isofol-receiving-recommendation-to-complete-the-global-phase-iii-agent-study-for-market-registration-as-planned-with-440-patients/ 2025-06-18T14:14:13+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-telefonkonferens-och-webcast-i-samband-med-att-isofol-erhaller-rekommendation-att-slutfora-den-globala-fas-iii-agent-studien-med-440-patienter-for-ett-marknadsgodkannande/ 2025-06-18T14:14:14+00:00 https://old.isofolmedical.com/sv/mfn_news/idsmb-rekommenderar-isofol-att-slutfora-den-globala-fas-iii-agent-studien-med-440-patienter-for-ett-marknadsgodkannande/ 2025-06-18T14:14:14+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-recommendation-from-idsmb-to-complete-the-global-phase-iii-agent-study-for-market-registration-as-planned-with-440-patients/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2020/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-idag-genuttrycksresultat-fran-den-slutford-fas-i-iia-iso-cc-005-studien-vid-asco-gi-2021-och-uppdateringar-tidpunkten-for-interimanalysen-i-agent-studien/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/mfn_news/isofol-to-present-gene-expression-results-from-the-completed-phase-i-iia-iso-cc-005-study-today-at-asco-gi-2021-and-updates-of-the-timing-of-the-interim-analysis-in-the-agent-study/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-nar-440-patienter-i-den-globala-fas-iii-studien-agent/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/mfn_news/isofol-reaches-440-patients-in-global-phase-iii-agent-study/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-lars-lind-malin-bjorkmo-bo-lundgren-och-mats-ola-palm-utsetts-som-ledamoter-i-bolagets-valberedning/ 2025-06-18T14:14:15+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2020/ 2025-06-18T14:14:16+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-a-conference-call-and-webcast-by-isofol-in-connection-with-the-entered-license-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada/ 2025-06-18T14:14:16+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-telefonkonferens-och-webcast-i-samband-med-att-isofol-ingar-licensavtal-med-paladin-labs-inc-for-att-kommersialisera-arfolitixorin-i-kanada/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-ingar-licensavtal-med-paladin-labs-inc-for-att-kommersialisera-arfolitixorin-i-kanada/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/sv/mfn_news/55-objektiv-tumorrespons-hos-extensionskohorterna-i-fas-i-iia-studien-iso-cc-005/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/mfn_news/55-overall-response-rate-on-the-safety-extension-cohorts-of-the-iso-cc-005-phase-i-iia-study/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/mfn_news/strengthened-patent-protection-for-arfolitixorin-in-japan/ 2025-06-18T14:14:17+00:00 https://old.isofolmedical.com/sv/mfn_news/starkt-patentskydd-for-arfolitixorin-i-japan/ 2025-06-18T14:14:18+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2020/ 2025-06-18T14:14:18+00:00 https://old.isofolmedical.com/mfn_news/invitation-to-a-conference-call-and-webcast-by-isofol-in-connection-with-the-entered-license-agreement-with-solasia/ 2025-06-18T14:14:18+00:00 https://old.isofolmedical.com/mfn_news/isofols-ceo-ulf-jungnelius-has-subscribed-for-all-warrants/ 2025-06-18T14:14:19+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-till-telefonkonferens-och-webcast-i-samband-med-det-tecknade-licensavtalet-mellan-isofol-och-solasia/ 2025-06-18T14:14:19+00:00 https://old.isofolmedical.com/mfn_news/isofol-enters-licensing-agreement-with-solasia-to-develop-and-commercialize-arfolitixorin-in-japan/ 2025-06-18T14:14:19+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-ingar-licensavtal-med-solasia-for-att-utveckla-och-kommersialisera-arfolitixorin-i-japan/ 2025-06-18T14:14:19+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-vd-ulf-jungnelius-har-tecknat-samtliga-teckningsoptioner/ 2025-06-18T14:14:19+00:00 https://old.isofolmedical.com/mfn_news/a-milestone-is-reached-with-the-inclusion-of-330-patients-in-the-agent-study-opening-up-for-the-interim-analysis/ 2025-06-18T14:14:20+00:00 https://old.isofolmedical.com/sv/mfn_news/milstolpe-med-330-patienter-inkluderade-i-agent-studien-vilket-oppnar-upp-for-interimanalysen/ 2025-06-18T14:14:20+00:00 https://old.isofolmedical.com/mfn_news/agent-study-update-with-regards-to-covid-19/ 2025-06-18T14:14:20+00:00 https://old.isofolmedical.com/sv/mfn_news/uppdatering-i-agent-studien-med-anledning-av-covid-19/ 2025-06-18T14:14:20+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-2020/ 2025-06-18T14:14:20+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-foretradesemission-overtecknad/ 2025-06-18T14:14:21+00:00 https://old.isofolmedical.com/mfn_news/isofols-rights-issue-oversubscribed/ 2025-06-18T14:14:21+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2019/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/sv/mfn_news/konsortium-av-investerare-forvarvar-teckningsratter-av-isofols-grundare-professor-bengt-gustavsson/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/mfn_news/consortium-of-investors-acquires-subscription-rights-from-isofols-founder-professor-bengt-gustavsson/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-i-isofol-medical-ab-publ/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-offentliggor-prospekt-i-samband-med-den-fullt-garanterade-foretradesemissionen-om-cirka-150-miljoner-kronor/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/mfn_news/isofol-publishes-prospectus-in-connection-with-the-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2020/ 2025-06-18T14:14:22+00:00 https://old.isofolmedical.com/sv/mfn_news/styrelsen-i-isofol-har-beslutat-om-en-fullt-garanterad-foretradesemission-om-cirka-150-miljoner-kronor/ 2025-06-18T14:14:23+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-of-directors-resolve-on-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-den-5-maj-2020/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-lakemedelskandidat-arfolitixorin-erhaller-annu-ett-clinical-use-patent-i-usa/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/mfn_news/isofols-drug-candidate-arfolitixorin-receives-additional-clinical-patent-approval-in-the-united-states/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/sv/mfn_news/mojlighet-till-forhandsrostning-vid-extra-bolagsstamma-den-5-maj-2020/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-senarelagger-arsstamman-2020/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/mfn_news/information-in-relation-to-covid-19/ 2025-06-18T14:14:24+00:00 https://old.isofolmedical.com/sv/mfn_news/information-med-anledning-av-covid-19/ 2025-06-18T14:14:25+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ/ 2025-06-18T14:14:25+00:00 https://old.isofolmedical.com/mfn_news/gene-expression-data-from-new-analysis-method-supports-that-a-larger-proportion-of-patients-will-benefit-from-arfolitixorin/ 2025-06-18T14:14:25+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-sin-avsikt-att-genomfora-en-fullt-garanterad-foretradesemission-om-cirka-150-miljoner-kronor-och-en-potentiell-overtilldelningsoption-om-upp-till-cirka-30-miljoner-kronor/ 2025-06-18T14:14:26+00:00 https://old.isofolmedical.com/sv/mfn_news/genexpressionsdata-fran-ny-analysmetod-stoder-att-storre-andel-av-patienter-kommer-att-ha-nytta-av-arfolitixorin/ 2025-06-18T14:14:26+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-its-intention-to-carry-out-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million-and-a-potential-over-allotment-option-of-up-to-approximately-sek-30-million/ 2025-06-18T14:14:26+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2019/ 2025-06-18T14:14:26+00:00 https://old.isofolmedical.com/sv/mfn_news/forsta-patienten-inkluderad-i-japan-i-isofols-fas-iii-agent-studie/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/mfn_news/the-first-patient-included-in-japan-in-isofols-phase-3-agent-study/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/sv/mfn_news/metoden-for-genexpressionsanalys-har-validerats-av-ett-kommersiellt-laboratorium/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/mfn_news/gene-expression-analysis-method-has-been-validated-by-a-commercial-laboratory/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/sv/mfn_news/over-200-patienter-har-nu-randomiserats-i-den-globala-fas-iii-agent-studien/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/mfn_news/over-200-patients-now-randomized-in-the-global-phase-3-agent-study/ 2025-06-18T14:14:27+00:00 https://old.isofolmedical.com/sv/mfn_news/fas-i-iia-studien-iso-cc-005-ar-avslutad/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/mfn_news/the-phase-1-2a-study-iso-cc-005-is-completed/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/sv/mfn_news/forsta-patienten-inkluderad-i-australien-i-isofols-fas-iii-agent-studie/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/mfn_news/the-first-patient-included-in-australia-in-isofols-phase-3-agent-study/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/mfn_news/patent-approved-in-japan-for-isofols-drug-candidate-arfolitixorin/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/sv/mfn_news/patent-godkant-i-japan-for-isofols-lakemedelskandidat-arfolitixorin/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/mfn_news/patent-detecting-how-patients-respond-to-folate-based-cancer-treatment-approved-in-the-usa/ 2025-06-18T14:14:29+00:00 https://old.isofolmedical.com/sv/mfn_news/patentgodkannande-i-usa-for-att-identifiera-hur-patienter-svarar-pa-folatbaserad-cancerbehandling/ 2025-06-18T14:14:30+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-lars-lind-malin-bjorkmo-bo-lundgren-och-mats-ola-palm-utsetts-som-ledamoter-i-bolagets-valberedning-2/ 2025-06-18T14:14:30+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-expanderar-den-pagaende-agent-studien-i-forsta-linjens-behandling-av-mcrc-till-australien/ 2025-06-18T14:14:30+00:00 https://old.isofolmedical.com/mfn_news/isofol-to-expand-global-phase-3-agent-trial-in-first-line-metastatic-colorectal-cancer-to-australia/ 2025-06-18T14:14:31+00:00 https://old.isofolmedical.com/mfn_news/isofols-board-appoints-dr-jarl-ulf-jungnelius-as-new-ceo-of-the-company/ 2025-06-18T14:14:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-styrelse-utser-dr-jarl-ulf-jungnelius-som-ny-vd-for-foretaget/ 2025-06-18T14:14:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2019/ 2025-06-18T14:14:31+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-far-positiv-feedback-fran-pmda-i-japan-och-utvidgar-den-pagaende-globala-och-pivotala-fas-iii-agent-studien-i-forsta-linjens-metastaserande-kolorektalcancer/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-positive-feedback-from-pmda-in-japan-expanding-ongoing-global-pivotal-phase-3-agent-trial-in-first-line-metastatic-colorectal-cancer/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-presentation-on-the-global-phase-3-study-of-arfolitixorin-in-metastatic-colorectal-cancer-at-2019-esmo-congress/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-en-posterpresentation-av-den-globala-fas-iii-studien-med-arfolitixorin-i-metastaserande-kolorektal-cancer-vid-esmo-kongressen-2019/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-att-ett-abstrakt-har-accepterats-for-presentation-vid-esmo-2019/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-has-been-accepted-for-presentation-at-the-2019-esmo-congress/ 2025-06-18T14:14:32+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2019/ 2025-06-18T14:14:33+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-management-team-evolution-with-appointment-of-dr-roger-tell-as-chief-medical-officer/ 2025-06-18T14:14:33+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utnamner-roger-tell-till-chief-medical-officer-cmo/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-recent-advisory-board-meeting-covering-development-plan-for-arfolitixorin/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/mfn_news/isofol-receives-clinical-use-patent-approval-in-the-united-states-for-drug-candidate-arfolitixorin/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-starker-patentportfoljen-erhaller-clinical-use-patent-i-usa-for-lakemedelskandidaten-arfolitixorin/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-election-of-three-new-board-members/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-val-av-tre-nya-styrelseledamoter/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-2019/ 2025-06-18T14:14:34+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2019/ 2025-06-18T14:14:35+00:00 https://old.isofolmedical.com/mfn_news/isofols-drug-candidate-arfolitixorin-receives-clinical-patent-approval-in-the-united-states/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-lakemedelskandidat-arfolitixorin-erhaller-clinical-use-patent-i-usa/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-rapporterar-58-overall-response-rate-hos-patienter-med-metastaserad-kolorektal-cancer-i-en-fas-1-2a-studie-med-arfolitixorin/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-58-overall-response-rate-in-patients-with-metastatic-colorectal-cancer-in-phase-1-2a-open-label-extension-study-with-arfolitixorin/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/sv/mfn_news/valkommen-till-arsstamma-i-isofol-medical-ab-publ/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2018/ 2025-06-18T14:14:36+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-appoints-carnegie-investment-bank-ab-publ-to-financial-advisor/ 2025-06-18T14:14:37+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-utser-carnegie-investment-bank-ab-publ-till-finansiell-radgivare/ 2025-06-18T14:14:37+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-bokslutskommunike-januari-december-2018/ 2025-06-18T14:14:37+00:00 https://old.isofolmedical.com/sv/mfn_news/samtliga-anstallda-deltar-i-isofols-nyinrattade-teckningsoptionsprogram/ 2025-06-18T14:14:37+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-all-employees-participate-in-newly-created-share-warrant-program/ 2025-06-18T14:14:38+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-participated-in-the-empowered-patient-podcast/ 2025-06-18T14:14:38+00:00 https://old.isofolmedical.com/wp-content/uploads/2019/01/podcast-EPP2.png https://old.isofolmedical.com/sv/mfn_news/intervju-med-isofols-styrelseordforande-i-dagens-industris-bilaga-life-science/ 2025-06-18T14:14:38+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-early-tumor-shrinkage-in-patients-with-colorectal-cancer-in-phase-1-2a-open-label-extension-study-with-arfolitixorin/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-rapporterar-tumorkrympning-hos-patienter-med-spridd-kolorektalcancer-efter-8-veckors-behandling-med-arfolitixorin/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/sv/mfn_news/forsta-patienten-inkluderad-i-isofols-agent-studie-en-pivotal-fas-3-studie-i-forsta-linjens-metastaserande-kolorektal-cancer/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/mfn_news/first-patient-enrolled-in-isofols-pivotal-phase-3-agent-study-in-1st-line-metastatic-colorectal-cancer/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/sv/mfn_news/rapport-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-17-december-2018/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-2/ 2025-06-18T14:14:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-september-2018/ 2025-06-18T14:14:40+00:00 https://old.isofolmedical.com/mfn_news/isofol-strengthens-executive-management-team-with-the-appointment-of-roger-tell-md-phd-as-chief-scientific-officer-and-senior-vice-president-of-clinical-development/ 2025-06-18T14:14:40+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-starker-ledningsgruppen-och-utnamner-roger-tell-md-phd-till-chief-scientific-officer-och-senior-vice-president-of-clinical-development/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-the-appointment-of-robert-marchesani-as-an-advisor-to-its-board-of-directors/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-robert-marchesani-som-radgivare-till-bolagets-styrelse/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-start-av-pivotal-klinisk-fas-3-studie-med-arfolitixorin-for-behandling-av-metastaserad-kolorektal-cancer/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-initiation-of-a-pivotal-phase-3-clinical-trial-of-arfolitixorin-for-the-treatment-of-metastatic-colorectal-cancer/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-lars-lind-malin-bjorkmo-och-bo-lundgren-utsetts-som-ledamoter-i-bolagets-valberedning/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/sv/mfn_news/rapport-fran-extra-bolagsstamma-i-isofol-medical-ab-publ-10-oktober-2018/ 2025-06-18T14:14:41+00:00 https://old.isofolmedical.com/sv/mfn_news/ny-ordforande-och-utokad-styrelse-i-isofol-medical-ab-publ/ 2025-06-18T14:14:42+00:00 https://old.isofolmedical.com/mfn_news/new-chairman-and-extended-board-at-isofol-medical-ab-publ/ 2025-06-18T14:14:42+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-extra-bolagsstamma-i-isofol-medical-ab-publ-3/ 2025-06-18T14:14:43+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-pa-pareto-securities-annual-health-care-conference-2018/ 2025-06-18T14:14:43+00:00 https://old.isofolmedical.com/sv/mfn_news/patent-godkant-i-usa-for-isofols-lakemedelskandidat-arfolitixorin/ 2025-06-18T14:14:43+00:00 https://old.isofolmedical.com/mfn_news/patent-approved-in-the-united-states-for-isofols-drug-candidate-arfolitixorin/ 2025-06-18T14:14:43+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-halvarsrapport-januari-juni-2018/ 2025-06-18T14:14:43+00:00 https://old.isofolmedical.com/sv/mfn_news/dagens-industri-publicerar-en-artikel-om-isofol-medical/ 2025-06-18T14:14:44+00:00 https://old.isofolmedical.com/mfn_news/redeye-and-isofol-are-inviting-to-the-live-broadcast-of-pre-asco-on-may-28th/ 2025-06-18T14:14:44+00:00 https://old.isofolmedical.com/sv/mfn_news/redeye-och-isofol-bjuder-in-till-direktsandningen-av-pre-asco-den-28-maj/ 2025-06-18T14:14:44+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-mars-2018/ 2025-06-18T14:14:44+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-ett-abstract-med-nya-forskningsresultat-har-publicerats-infor-arets-asco-kongress-i-chicago/ 2025-06-18T14:14:44+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-with-new-research-resultshas-been-published-for-this-years-asco-congress-in-chicago/ 2025-06-18T14:14:45+00:00 https://old.isofolmedical.com/sv/mfn_news/rapport-fran-arsstamma-i-isofol-medical-ab-publ-2018/ 2025-06-18T14:14:45+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-en-s-k-sarskild-protokollbedomnings-process-spa-med-fda-pagar/ 2025-06-18T14:14:45+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-fdas-feedback-from-the-ongoing-special-protocol-assessment-spa-process/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-offentliggor-arsredovisning-och-bolagsstyrningsrapport-for-2017/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-describing-a-genetic-prediction-of-treatment-response-in-crc-treatment-to-be-unveiled-at-asco-2018/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-ett-abstrakt-rorande-genetikens-inverkan-pa-behandlingsprognos-vid-crc-behandling-skall-presenteras-vid-asco-2018/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-i-isofol-medical-ab-publ-2/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-has-selected-arfolitixorin-dose-for-the-phase-iii-pivotal-study-iso-cc-007/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-valt-dos-pa-lakemedelskandidaten-arfolitixorin-infor-registreringsstudien-iso-cc-007/ 2025-06-18T14:14:46+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-publicerar-bokslutskommunike-januari-december-2017/ 2025-06-18T14:14:47+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-inforlivar-varldshalsoorganisationen-whos-rekommenderade-generiska-namn-inn-arfolitixorin-for-modufolin/ 2025-06-18T14:14:48+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-adopts-the-world-health-organization-recommended-name-inn-arfolitixorin-for-modufolin/ 2025-06-18T14:14:48+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-rapporterar-framgangsrikt-utfall-fran-vetenskapliga-radgivningen-med-ema/ 2025-06-18T14:14:48+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-successful-outcome-from-the-scientific-advice-with-the-ema/ 2025-06-18T14:14:48+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-vd-styrelsemedlemmar-och-anstallda-tecknar-aktier-for-7-655-136-sek-med-stod-av-tecknings-och-personaloptioner/ 2025-06-18T14:14:48+00:00 https://old.isofolmedical.com/mfn_news/isofols-ceo-directors-and-employees-converts-stock-and-employee-options-and-subscribe-shares-for-sek-7-655-136/ 2025-06-18T14:14:49+00:00 https://old.isofolmedical.com/mfn_news/positive-treatment-results-with-modufolin-arfolitixorin-will-be-published-at-a-cancer-congress-asco-in-the-us/ 2025-06-18T14:14:49+00:00 https://old.isofolmedical.com/sv/mfn_news/positivt-behandlingsutfall-med-modufolin-arfolitixorin-publiceras-pa-cancersymposium-asco-i-usa/ 2025-06-18T14:14:49+00:00 https://old.isofolmedical.com/sv/mfn_news/framgangsrikt-mote-med-fda-om-fas-ii-avslutningen-och-upplagget-av-fas-iii-studie-for-modufolin/ 2025-06-18T14:14:49+00:00 https://old.isofolmedical.com/mfn_news/successful-end-of-phase-2-meeting-with-fda-and-phase-3-program-for-modufolin-agreed/ 2025-06-18T14:14:50+00:00 https://old.isofolmedical.com/mfn_news/isofol-reports-positive-efficacy-data-for-modufolin-arfolitixorin-from-patients-treated-for-metastatic-colorectal-cancer/ 2025-06-18T14:14:50+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-tillkannager-positiva-effektdata-for-modufolin-arfolitixorin-hos-patienter-som-behandlas-for-metastaserande-kolorektalcancer/ 2025-06-18T14:14:50+00:00 https://old.isofolmedical.com/mfn_news/isofol-to-present-at-the-10th-annual-biotech-showcase-conference/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-kommer-presentera-pa-arets-uppsattning-av-biotech-showcase-conference-i-san-fransisco/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-ett-abstract-rorande-effekt-av-modufolin-vid-behandling-av-kolorektalcancer-presenteras-pa-asco-gi-2018/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-regarding-modufolins-efficacy-in-colorectal-cancer-treatment-will-be-presented-at-asco-gi-2018/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-pa-stora-aktiedagen-i-goteborg/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-pa-redeye-life-science-seminar-2017/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/sv/mfn_news/delarsrapport-januari-september-2017/ 2025-06-18T14:14:51+00:00 https://old.isofolmedical.com/mfn_news/isofol-appoints-gustaf-albert-as-chief-financial-officer/ 2025-06-18T14:14:52+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-gustaf-albert-till-chief-financial-officer/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-modufolin-som-raddningsbehandling-vid-osteosarkom-hos-barn-ar-sakert-och-forebygger-hdmtx-relaterad-toxicitet/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-modufolin-as-a-rescue-therapy-in-the-treatment-of-osteosarcoma-in-children-is-safe-and-preventive-of-hdmtx-toxicities/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-har-genomfort-ett-framgangsrikt-typ-c-mote-med-amerikanska-fda-gallande-modufolin-for-behandling-av-metastaserande-kolorektalcancer/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-announces-successful-type-c-meeting-with-fda-regarding-its-drug-candidate-modufolin-for-treatment-of-metastatic-colorectal-cancer/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/mfn_news/from-the-ongoing-iso-cc-005-study-isofol-reports-initial-indications-of-efficacy-of-modufolin-in-patients-with-metastatic-colorectal-cancer/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-initiala-resultat-fran-pagaende-studien-iso-cc-005-indikerar-effekt-av-modufolin-vid-behandling-av-metastaserad-kolorektalcancer/ 2025-06-18T14:14:53+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-halvarsrapport-2017-januari-2017-juni-2017/ 2025-06-18T14:14:54+00:00 https://old.isofolmedical.com/mfn_news/isofols-appoints-sven-erickson-as-chief-commercial-officer/ 2025-06-18T14:14:54+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-utser-dr-sven-erickson-till-chief-commercial-officer/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-upprattar-samarbete-med-prof-sten-nilsson-och-dr-alain-herrera-som-del-av-forberedelserna-infor-registreringsstudien-med-modufolin/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/mfn_news/isofol-establish-cooperation-with-prof-sten-nilsson-and-dr-alain-herrera-in-preparation-for-the-upcoming-pivotal-trial-with-modufolin/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-ett-abstract-om-modufolin-vid-osteosarkombehandling-presenteras-pa-esmo-2017/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-that-an-abstract-about-modufolin-in-osteosarcoma-treatment-will-be-presented-at-esmo-2017/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/sv/mfn_news/scrip-intelligence-en-ledande-kalla-for-strategisk-analys-i-lakemedelsindustrin-publicerar-artikel-om-isofol-medical/ 2025-06-18T14:14:55+00:00 https://old.isofolmedical.com/mfn_news/scrip-intelligence-a-leading-source-of-news-and-strategic-analysis-for-the-global-pharmaceutical-industry-publish-article-about-isofol-medical/ 2025-06-18T14:14:56+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-enrollerat-och-doserat-de-forsta-patienterna-i-ind-studien-iso-ff-001/ 2025-06-18T14:14:56+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-enrolled-and-dosed-its-first-group-of-patients-in-the-ind-study-iso-ff-001/ 2025-06-18T14:14:56+00:00 https://old.isofolmedical.com/mfn_news/new-scientific-findings-strengthen-rationale-and-motivation-for-isofol-medical-to-conduct-the-pivotal-iso-cc-007-study/ 2025-06-18T14:14:56+00:00 https://old.isofolmedical.com/sv/mfn_news/nya-forskningsresultat-starker-isofols-rational-och-motivering-till-att-genomfora-den-pivotala-iso-cc-007-studien/ 2025-06-18T14:14:57+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-initiated-five-additional-study-sites-in-the-iso-cc-005-study-in-which-modufolin-is-evaluated-in-colorectal-cancer/ 2025-06-18T14:14:57+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-oppnat-fem-ytterligare-studiecentra-i-iso-cc-005-studien-i-vilken-modufolin-utvarderas-for-behandling-av-kolorektalcancer/ 2025-06-18T14:14:57+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-presenterar-pa-smabolagsdagen-12-juni-2017/ 2025-06-18T14:14:57+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-utser-pareto-securities-till-likviditetsgarant/ 2025-06-18T14:14:57+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-meddelar-att-ett-abstract-har-publicerats-infor-arets-asco-kongress/ 2025-06-18T14:14:58+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-publication-of-an-abstract-for-the-2017-asco-annual-meeting/ 2025-06-18T14:14:58+00:00 https://old.isofolmedical.com/sv/mfn_news/kommunike-fran-arsstamma-i-isofol-medical-ab-publ-den-16-maj-2017/ 2025-06-18T14:14:58+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-delarsrapport-q1-2017-januari-2017-mars-2017/ 2025-06-18T14:14:58+00:00 https://old.isofolmedical.com/mfn_news/pareto-securities-has-notified-isofol-medical-ab-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken/ 2025-06-18T14:14:58+00:00 https://old.isofolmedical.com/sv/mfn_news/pareto-securities-har-meddelat-isofol-medical-ab-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits/ 2025-06-18T14:14:59+00:00 https://old.isofolmedical.com/mfn_news/isofol-accepted-for-presentation-of-abstract-at-the-2017-asco-annual-meeting/ 2025-06-18T14:14:59+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-godkant-for-presentation-av-abstract-pa-arets-asco-kongress/ 2025-06-18T14:14:59+00:00 https://old.isofolmedical.com/sv/mfn_news/pareto-securities-har-meddelat-isofol-medical-ab-publ-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/mfn_news/pareto-securities-has-notified-isofol-medical-ab-publ-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/sv/mfn_news/kallelse-till-arsstamma-i-isofol-medical-ab-publ-3/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/sv/mfn_news/pareto-securities-har-meddelat-isofol-medical-ab-att-stabiliseringsatgarder-avseende-bolagets-aktier-har-vidtagits-2/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/mfn_news/pareto-securities-has-notified-isofol-medical-ab-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken-2/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-framgangsrikt-avslutat-iso-mtx-003-studien-i-vilken-modufolin-utvarderas-som-raddningsterapi-rescue-therapy/ 2025-06-18T14:15:00+00:00 https://old.isofolmedical.com/mfn_news/isofol-has-successfully-completed-the-iso-mtx-003-study-in-which-modufolin-is-evaluated-as-rescue-therapy/ 2025-06-18T14:15:01+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-storsta-agare-och-medgrundare-forvarvar-aktier-i-bolaget/ 2025-06-18T14:15:02+00:00 https://old.isofolmedical.com/mfn_news/isofols-largest-shareholder-and-co-founder-acquires-shares-in-the-company/ 2025-06-18T14:15:02+00:00 https://old.isofolmedical.com/mfn_news/isofols-chairman-of-the-board-acquires-shares-in-the-company/ 2025-06-18T14:15:02+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-styrelseordforande-forvarvar-aktier-i-bolaget/ 2025-06-18T14:15:03+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-announces-the-outcome-of-the-offering-trading-on-nasdaq-first-north-premier-commences-today/ 2025-06-18T14:15:03+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-offentliggor-utfallet-av-erbjudandet-handel-pa-nasdaq-first-north-premier-inleds-idag/ 2025-06-18T14:15:03+00:00 https://old.isofolmedical.com/sv/mfn_news/privata-affarer-publicerar-koprekommendation-om-isofol/ 2025-06-18T14:15:03+00:00 https://old.isofolmedical.com/sv/mfn_news/investerarbrevet-publicerar-artikel-om-isofol/ 2025-06-18T14:15:03+00:00 https://old.isofolmedical.com/sv/mfn_news/gp-publicerar-artikel-om-isofols-borsnotering/ 2025-06-18T14:15:04+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-isofol-kommer-presentera-sin-planerade-borsnotering-i-stockholm-29-mars/ 2025-06-18T14:15:04+00:00 https://old.isofolmedical.com/mfn_news/invitation-isofol-will-present-its-contemplated-ipo-in-stockholm-on-march-29/ 2025-06-18T14:15:05+00:00 https://old.isofolmedical.com/mfn_news/invitation-isofol-will-present-its-contemplated-ipo-in-goteborg-on-march-22/ 2025-06-18T14:15:05+00:00 https://old.isofolmedical.com/sv/mfn_news/inbjudan-isofol-kommer-presentera-sin-planerade-borsnotering-i-goteborg-22-mars/ 2025-06-18T14:15:05+00:00 https://old.isofolmedical.com/mfn_news/listing-of-isofol-medical-on-nasdaq-first-north-premier-and-publication-of-prospectus/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/sv/mfn_news/notering-av-isofol-medical-pa-nasdaq-first-north-premier-och-offentliggorande-av-prospekt/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-bokslutskommunike-januari-december-2016/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-avser-att-noteras-pa-nasdaq-first-north-premier/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/mfn_news/isofol-announces-its-intention-to-list-on-nasdaq-first-north-premier/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-ansoker-om-viktigt-patent-i-usa/ 2025-06-18T14:15:06+00:00 https://old.isofolmedical.com/mfn_news/isofol-files-important-new-us-patent-application/ 2025-06-18T14:15:07+00:00 https://old.isofolmedical.com/sv/mfn_news/extra-bolagsstamma-i-isofol-medical-ab/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-far-klartecken-fran-fda-att-paborja-kliniskt-program-inom-kolorektalcancer-med-modufolin/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/mfn_news/fda-clears-isofols-ind-application-to-start-clinical-program-within-colorectal-cancer-with-modufolin/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/sv/mfn_news/extra-bolagsstamma-i-isofol-medical-ab-2/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-present-at-aktietorget-investor-meeting/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-has-successfully-advanced-to-the-next-dose-level-of-modufolin-in-a-phase-i-ii-clinical-trial-in-colorectal-cancer/ 2025-06-18T14:15:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-share-issue-oversubscribed-securing-over-sek-39-million-to-strengthen-the-ongoing-phase-ii-clinical-development-program-of-modufolin/ 2025-06-18T14:15:09+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-foretradesemission-overtecknad-utnyttjar-overtilldelning-till-japansk-samarbetspartner/ 2025-07-04T16:00:00+00:00 https://old.isofolmedical.com/mfn_news/isofols-rights-issue-fully-subscribed-exercises-overallotment-for-japanese-partner/ 2025-07-04T16:00:00+00:00 https://old.isofolmedical.com/mfn_news/isofol-medical-ab-publ-publishes-interim-report-january-june-2025/ 2025-09-26T13:53:07+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-medical-ab-publ-publicerar-delarsrapport-januari-juni-2025/ 2025-09-26T13:53:07+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-har-genomfort-ett-framgangsrikt-pre-ind-mote-med-fda-for-arfolitixorin/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-successfully-completes-pre-ind-meeting-with-the-fda-for-arfolitixorin/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/mfn_news/new-number-of-shares-and-votes-in-isofol/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/sv/mfn_news/nytt-antal-aktier-och-roster-i-isofol/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-bjuder-in-till-presentation-av-delarsrapporten-for-andra-kvartalet-2025/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-invites-to-a-presentation-of-the-interim-report-for-the-second-quarter-2025/ 2025-09-26T13:53:08+00:00 https://old.isofolmedical.com/mfn_news/isofol-completes-transfer-of-shares-to-solasia-pharma-following-a-successful-rights-issue/ 2025-09-26T13:55:39+00:00 https://old.isofolmedical.com/sv/mfn_news/isofol-slutfor-transaktion-av-aktier-till-solasia-pharma-efter-framgangsrik-foretradesemission/ 2025-09-26T13:55:55+00:00 https://old.isofolmedical.com/sv/mfn_news/isofols-kliniska-studie-av-arfolitixorin-nar-annu-ett-viktigt-delmal/ 2025-09-30T13:00:00+00:00 https://old.isofolmedical.com/mfn_news/isofols-clinical-study-with-arfolitixorin-reaches-another-important-milestone/ 2025-09-30T13:00:00+00:00 https://old.isofolmedical.com/sv/mfn_news/ 2025-09-30T13:00:00+00:00